Contrastively, no significant difference was observed in clinical GVHD scores of CD45RA-depleted and CD45RA/CD276-depleted graft recipients in the HLA-DR4-matched setting (Fig. 3b, c). This evidence concerns the gene CD276 and graft versus host disease.